Ischemia-modified albumin in children with clinically suspected acute myocarditis: diagnostic performance and incremental value beyond conventional biomarkers - Scorecard - MDSpire
Advertisement
Ischemia-modified albumin in children with clinically suspected acute myocarditis: diagnostic performance and incremental value beyond conventional biomarkers
Clinical Scorecard: Evaluating Ischemia-Modified Albumin in Pediatric Patients with Suspected Acute Myocarditis: Diagnostic Efficacy and Added Value Compared to Standard Biomarkers
At a Glance
Category
Detail
Condition
Pediatric Acute Myocarditis
Key Mechanisms
Inflammatory, ischemic, and hemodynamic components
Target Population
Children aged 1 month to 18 years with clinically suspected acute myocarditis
Care Setting
Pediatric cardiology outpatient clinic, general pediatrics outpatient clinic, and pediatric emergency department
Key Highlights
IMA levels were significantly higher in myocarditis patients compared to controls.
Diagnostic performance of IMA alone was modest (AUC 0.64).
Conventional biomarkers (e.g., troponin I, NT-proBNP) showed stronger discrimination.
IMA may serve as an adjunctive biomarker rather than a primary diagnostic tool.
All children in the myocarditis group were symptomatic at presentation.
Guideline-Based Recommendations
Diagnosis
Diagnosis relies on clinical findings, electrocardiography, echocardiography, and cardiac biomarkers.
Management
Management strategies should follow the 2021 American Heart Association and 2024 American College of Cardiology guidelines.
Monitoring & Follow-up
Monitor for symptoms of heart failure and arrhythmias in suspected cases.
Risks
Potential for persistent ventricular dysfunction or sudden cardiac death.
Patient & Prescribing Data
Children with clinically suspected acute myocarditis.
No specific treatment insights provided; focus on biomarker evaluation.
Clinical Best Practices
Integrate IMA testing with conventional biomarkers for a comprehensive assessment.
Consider IMA as a supplementary tool in the diagnostic process.
